Wells Fargo Initiates Coverage On Omnicell with Overweight Rating, Announces Price Target of $203
Wells Fargo analyst Stan Berenshteyn initiates coverage on Omnicell (NASDAQ:OMCL) with a Overweight rating and announces Price Target of $203.
Craig-Hallum Maintains Buy on Omnicell, Raises Price Target to $205
Craig-Hallum analyst Matt Hewitt maintains Omnicell (NASDAQ:OMCL) with a Buy and raises the price target from $170 to $205.
Recap: Omnicell Q3 Earnings
Omnicell (NASDAQ:OMCL) reported its Q3 earnings results on Tuesday, November 2, 2021 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Omnicell reported EPS of $1.08 versus an estimate of $0.91.
Omnicell Q3 Adj. EPS $1.08 Beats $0.91 Estimate, Sales $296.00M Beat $284.74M Estimate
Omnicell (NASDAQ:OMCL) reported quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $0.91 by 18.68 percent. This is a 80 percent increase over earnings of $0.60 per share from the same
Earnings Scheduled For November 2, 2021
Companies Reporting Before The Bell
• Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion.
BTIG Maintains Buy on Omnicell, Raises Price Target to $200
BTIG analyst David Larsen maintains Omnicell (NASDAQ:OMCL) with a Buy and raises the price target from $175 to $200.
Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology-Enabled Services with Summer 2021 Release
New capabilities focus on superior customer experience and innovation to drive maximum value sooner; deliver improved workflow efficiency, expanded automation, and enhanced medication management intelligence
Omnicell,
Omnicell Beats On Q2 Earnings, Issues Promising Q3 Guidance
Omnicell Inc (NASDAQ:OMCL) reported second-quarter FY21 revenue growth of 36.6% year-on-year to $272.7 million, beating the analyst consensus of $268.5 million.…
Omnicell Q2 Adj. EPS $0.97 Beats $0.82 Estimate, Sales $272.74M Beat $268.51M Estimate
Omnicell (NASDAQ:OMCL) reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.82 by 18.29 percent. This is a 162.16 percent increase over earnings of $0.37 per share from the same